英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
incendit查看　incendit　在百度字典中的解释百度英翻中〔查看〕
incendit查看　incendit　在Google字典中的解释Google英翻中〔查看〕
incendit查看　incendit　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • 3 checkpoints during the regulatory process | Within3
    What are the key checkpoints in the drug development regulatory process? Read on to learn more about the important steps What milestones must a biopharma company achieve before and after a clinical trial?
  • From Lab to Launch: A Regulatory-Driven Commercialization Roadmap for a . . .
    Preparing regulatory packages, interacting with regulatory agencies, and post-launch compliance are critical stages to ensure the safety and efficacy of the product Below is a detailed look at each of these essential phases
  • Major Steps to Launching a New Pharmaceutical Product | Magnolia Market . . .
    Learn the major steps involved in launching a new pharmaceutical product, from regulatory approval and market access to strategic marketing and post-launch evaluation
  • Key trends shaping biopharma dealmaking in 2025 - McKinsey Company
    Innovation-focused dealmaking saw its peak during the COVID-19 pandemic, when medical urgencies came into sharp focus and brought increased investment and activity, especially in early-stage R D After that spike, however, the industry saw a steep decline in the number of deals executed annually, both for M A and partnerships
  • Mastering New Product Launch Readiness in the Pharmaceutical Industry . . .
    A successful new product launch in the pharmaceutical industry requires detailed planning and coordination across various departments, from regulatory filings and manufacturing readiness to supply chain management and quality control This research article outlines a structured, step-by-step approach
  • Regulatory Roadmap: Essential Steps in Drug Approval and Beyond
    Navigating the intricate pathways of drug approval is a pivotal endeavor for pharmaceutical companies aiming to bring new therapies to market The process, governed by stringent regulatory frameworks, ensures that all pharmaceutical products meet the highest safety, efficacy, and quality standards
  • Regulatory review of new drugs | Cytiva
    From the submission of an investigational new drug (IND) application, regulators will want to see a purposeful plan to assess drug safety, quality, and efficacy over time Below, we outline some basic information and helpful strategies to facilitate efficient drug review
  • Early Drug Development: A Regulatory Perspective - PQRI
    “FDA's primary objectives in reviewing an IND are, in all phases of the investigation, to assure the safety and rights of subjects, and, in Phase 2 and 3, to help assure that the quality of the scientific evaluation of drugs is adequate to permit an evaluation of the drug's effectiveness and safety”
  • Checklist Method | The Complete Checklist for Launching a New
    It is crucial to work closely with regulatory bodies to ensure that all necessary approvals are secured before product launch Key steps include: Preclinical and Clinical Trials: Conduct rigorous preclinical and clinical testing to demonstrate the product’s safety and efficacy
  • REGULATORY CONSIDERATIONS IN CONTROLLED ELIVERY
    Investigational New Drug Application (INDA) At some point during drug development (see Figure 13 1), the decision is made to initiate an INDA for a drug with desirable bioactivity





中文字典-英文字典  2005-2009